Related Experiment Videos
New developments in the management of ischemic heart disease. Commentary
1Department of Cardiology, Mayo Clinic, Rochester, MN 55905, USA.
Current Opinion in Cardiology
|July 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Human torture: description and sequelae of 104 cases.
Canadian family physician Medecin de famille canadien·2011
Community health centres: an overview of the experience.
Canadian family physician Medecin de famille canadien·2010
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH·2009
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.
Journal of thrombosis and haemostasis : JTH·2005
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.
Journal of thrombosis and haemostasis : JTH·2004
Key advances in secondary prevention after coronary artery bypass grafting.
Current opinion in cardiology·2026
Coronary artery bypass grafting in women: optimizing operative outcomes.
Current opinion in cardiology·2026
The role of artificial intelligence in the diagnosis of pericardial constriction.
Current opinion in cardiology·2026
Contemporary evidence for multiarterial grafting in coronary artery bypass surgery.
Current opinion in cardiology·2026
Artificial intelligence for the assessment of diastolic function.
Current opinion in cardiology·2026
Contemporary medical management of left ventricular assist device patients: integrating sex-specific perspectives.
Current opinion in cardiology·2026
Trojan mast cells: repurposing allergy for targeted oncolytic delivery.
Trends in pharmacological sciences·2026
Remote photobiomodulation: A systemic approach to neuroprotection.
International review of neurobiology·2026
Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026